BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 29605512)

  • 1. A novel tropomyosin-related kinase A inhibitor, KK5101 to treat pancreatic cancer.
    Fang Z; Han B; Jung KH; Lee JH; El-Damasy AK; Gadhe CG; Kim SJ; Yan HH; Park JH; Lee JE; Kang YW; Pae AN; Keum G; Hong SS
    Cancer Lett; 2018 Jul; 426():25-36. PubMed ID: 29605512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cancer effect of HS-345, a new tropomyosin-related kinase A inhibitor, on human pancreatic cancer.
    Seo JH; Jung KH; Son MK; Yan HH; Ryu YL; Kim J; Lee JK; Hong S; Hong SS
    Cancer Lett; 2013 Sep; 338(2):271-81. PubMed ID: 23587795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status.
    Chao MW; Chang LH; Tu HJ; Chang CD; Lai MJ; Chen YY; Liou JP; Teng CM; Pan SL
    Clin Epigenetics; 2019 May; 11(1):85. PubMed ID: 31142371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway.
    Yang L; Lin S; Kang Y; Xiang Y; Xu L; Li J; Dai X; Liang G; Huang X; Zhao C
    J Exp Clin Cancer Res; 2019 Jan; 38(1):31. PubMed ID: 30674340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell-Like Phenotype.
    Bian Y; Teper Y; Mathews Griner LA; Aiken TJ; Shukla V; Guha R; Shinn P; Xin HW; Pflicke H; Powers AS; Li D; Jiang JK; Patel P; Rogers SA; Aubé J; Ferrer M; Thomas CJ; Rudloff U
    Mol Cancer Ther; 2019 Nov; 18(11):2097-2110. PubMed ID: 31395684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Focal Adhesion Kinase and Resistance to mTOR Inhibition in Pancreatic Neuroendocrine Tumors.
    François RA; Maeng K; Nawab A; Kaye FJ; Hochwald SN; Zajac-Kaye M
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 25971297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
    Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TrkA is a binding partner of NPM-ALK that promotes the survival of ALK
    Shi W; George SK; George B; Curry CV; Murzabdillaeva A; Alkan S; Amin HM
    Mol Oncol; 2017 Sep; 11(9):1189-1207. PubMed ID: 28557340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fascaplysin Exerts Anti-Cancer Effects through the Downregulation of Survivin and HIF-1α and Inhibition of VEGFR2 and TRKA.
    Oh TI; Lee YM; Nam TJ; Ko YS; Mah S; Kim J; Kim Y; Reddy RH; Kim YJ; Hong S; Lim JH
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28961193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
    Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
    Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activation.
    Wei WT; Chen H; Ni ZL; Liu HB; Tong HF; Fan L; Liu A; Qiu MX; Liu DL; Guo HC; Wang ZH; Lin SZ
    Int J Oncol; 2011 Dec; 39(6):1381-90. PubMed ID: 21805032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genistein induced anticancer effects on pancreatic cancer cell lines involves mitochondrial apoptosis, G
    Bi YL; Min M; Shen W; Liu Y
    Phytomedicine; 2018 Jan; 39():10-16. PubMed ID: 29433670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from Kras(G12D) mice.
    Huang M; Tang SN; Upadhyay G; Marsh JL; Jackman CP; Srivastava RK; Shankar S
    Cancer Lett; 2014 Oct; 353(1):32-40. PubMed ID: 25050737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling.
    Zheng H; Yang L; Kang Y; Chen M; Lin S; Xiang Y; Li C; Dai X; Huang X; Liang G; Zhao C
    Mol Carcinog; 2019 Apr; 58(4):565-576. PubMed ID: 30520143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition of cell proliferation and induction of apoptosis in pancreatic ductal adenocarcinoma cells by verrucarin A, a macrocyclic trichothecene, is associated with the inhibition of Akt/NF-кB/mTOR prosurvival signaling.
    Deeb D; Gao X; Liu Y; Zhang Y; Shaw J; Valeriote FA; Gautam SC
    Int J Oncol; 2016 Sep; 49(3):1139-47. PubMed ID: 27573873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plumbagin, isolated from Plumbago zeylanica, induces cell death through apoptosis in human pancreatic cancer cells.
    Chen CA; Chang HH; Kao CY; Tsai TH; Chen YJ
    Pancreatology; 2009; 9(6):797-809. PubMed ID: 20110748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the yin and the yang: combined inhibition of the tyrosine kinase c-Src and the tyrosine phosphatase SHP-2 disrupts pancreatic cancer signaling and biology in vitro and tumor formation in vivo.
    Gomes EG; Connelly SF; Summy JM
    Pancreas; 2013 Jul; 42(5):795-806. PubMed ID: 23271399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trk inhibitor GNF‑5837 suppresses the tumor growth, survival and migration of renal cell carcinoma.
    Chen Y; Wang H; Chen Y; Wang M; Ding G; Li T
    Oncol Rep; 2019 Nov; 42(5):2039-2048. PubMed ID: 31485624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel polysaccharide, isolated from Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical cancer HeLa cells through an intrinsic apoptotic pathway.
    Cao W; Li XQ; Wang X; Fan HT; Zhang XN; Hou Y; Liu SB; Mei QB
    Phytomedicine; 2010 Jul; 17(8-9):598-605. PubMed ID: 20092988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of potent pyruvate dehydrogenase kinase 4 inhibitors from plants in pancreatic cancer.
    Tambe Y; Terado T; Kim CJ; Mukaisho KI; Yoshida S; Sugihara H; Tanaka H; Chida J; Kido H; Yamaji K; Yamamoto T; Nakano H; Omura S; Inoue H
    Mol Carcinog; 2019 Oct; 58(10):1726-1737. PubMed ID: 31106493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.